Direct Measurement of Peptide-Specific CD8+ T Cells Using HLA-A2:Ig Dimer for Monitoring the In Vivo Immune Response to a HER2/neu Vaccine in Breast and Prostate Cancer Patients

By Woll Michael M.   Fisher Christine M.   Ryan Gayle B.   Gurney Jennifer M.   Storrer Catherine E.   Ioannides Constantin G.   Shriver Craig D.   Moul Judd W.   Mcleod David G.   Ponniah Sathibalan   Peoples George E.  

Journal of Clinical Immunology, Vol. 24, Iss. 4, 2004-07 ,pp. : 449-461

Springer Publishing Company

Access to resources Recommend Favorite

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu - identification of a CD34+/CD7+ NK progenitor

By Cooley S.   Burns L.J.   Repka T.   Miller J.S.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1533-1541

Elsevier

Access to resources Recommend Favorite

Fluorescence in Situ Hybridization Study of HER-2/neu Oncogene Amplification in Prostate Cancer

By Mark H.F.L.   Feldman D.   Das S.   Kye H.   Mark S.   Sun C.-L.   Samy M.  

Experimental and Molecular Pathology, Vol. 66, Iss. 2, 1999-06 ,pp. : 170-178

Elsevier

Access to resources Recommend Favorite

Shared Antigenic Epitopes and Pathobiological Functions of Anti-p185 her2/neu Monoclonal Antibodies

By Zhang H.   Wang Q.   Montone K.T.   Peavey J.E.   Drebin J.A.   Greene M.I.   Murali R.  

Experimental and Molecular Pathology, Vol. 67, Iss. 1, 1999-09 ,pp. : 15-25

Elsevier

Access to resources Recommend Favorite

HER-2/neu Oncogene Amplification in Stage I And Stage III Ovarian Papillary Serous Carcinoma

By Afify A.M.   Werness B.A.   Mark H.F.L.  

Experimental and Molecular Pathology, Vol. 66, Iss. 2, 1999-06 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite